Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sideris

Showing results (1151-1160 of 1,209) with videos related to

Pageof 121
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitorTimothy P Heffron, Megan Berry, Georgette Castanedo, et al.
Journal of Medicinal Chemistry|December 4, 2012
Potent, selective, and orally bioavailable inhibitors of the mammalian target of rapamycin kinase domain exhibiting single agent antiproliferative activityMichael F T Koehler, Philippe Bergeron, Elizabeth Blackwood, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFRMarian C Bryan, Daniel J Burdick, Bryan K Chan, et al.
Clinical Colorectal Cancer|November 25, 2023
Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in CanadaWinson Y Cheung, Setareh Samimi, Kim Ma, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2013
Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenasePeter S Dragovich, Benjamin P Fauber, Laura B Corson, et al.
Resuscitation|December 21, 2019
Low rates of immediate coronary angiography among young adults resuscitated from sudden cardiac arrestVictor Waldmann, Nicole Karam, Julien Rischard, et al.
Journal of Medicinal Chemistry|April 19, 2011
Potent, selective, and orally bioavailable inhibitors of mammalian target of rapamycin (mTOR) kinase based on a quaternary substituted dihydrofuropyrimidineFrederick Cohen, Philippe Bergeron, Elizabeth Blackwood, et al.
JACC. Basic to Translational Science|December 19, 2025
The Role of Sphingolipids in Myocardial Recovery Mediated by Mechanical Unloading and Circulatory SupportRana Hamouche, Sean M Tatum, Elizabeth Dranow, et al.
Journal of Cardiac Failure|September 19, 2024
Integration of Patient Reported Quality-of-life Data into Risk Assessment in Heart FailureKonstantinos Sideris, Mingyuan Zhang, Peter Wohlfahrt, et al.
Clinical and Translational Medicine|May 1, 2021
Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancerKaren Gambaro, Maud Marques, Suzan McNamara, et al.
Pageof 121

Showing results (1151-1160 of 1,209) with videos related to

Sort By:
Pageof 121
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitorTimothy P Heffron, Megan Berry, Georgette Castanedo, et al.
Journal of Medicinal Chemistry|December 4, 2012
Potent, selective, and orally bioavailable inhibitors of the mammalian target of rapamycin kinase domain exhibiting single agent antiproliferative activityMichael F T Koehler, Philippe Bergeron, Elizabeth Blackwood, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFRMarian C Bryan, Daniel J Burdick, Bryan K Chan, et al.
Clinical Colorectal Cancer|November 25, 2023
Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in CanadaWinson Y Cheung, Setareh Samimi, Kim Ma, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2013
Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenasePeter S Dragovich, Benjamin P Fauber, Laura B Corson, et al.
Resuscitation|December 21, 2019
Low rates of immediate coronary angiography among young adults resuscitated from sudden cardiac arrestVictor Waldmann, Nicole Karam, Julien Rischard, et al.
Journal of Medicinal Chemistry|April 19, 2011
Potent, selective, and orally bioavailable inhibitors of mammalian target of rapamycin (mTOR) kinase based on a quaternary substituted dihydrofuropyrimidineFrederick Cohen, Philippe Bergeron, Elizabeth Blackwood, et al.
JACC. Basic to Translational Science|December 19, 2025
The Role of Sphingolipids in Myocardial Recovery Mediated by Mechanical Unloading and Circulatory SupportRana Hamouche, Sean M Tatum, Elizabeth Dranow, et al.
Journal of Cardiac Failure|September 19, 2024
Integration of Patient Reported Quality-of-life Data into Risk Assessment in Heart FailureKonstantinos Sideris, Mingyuan Zhang, Peter Wohlfahrt, et al.
Clinical and Translational Medicine|May 1, 2021
Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancerKaren Gambaro, Maud Marques, Suzan McNamara, et al.
Pageof 121